The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Panmure Gordon Raises DCC To Buy After Update

Thu, 11th Feb 2016 09:37

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
Panmure Gordon Ups DCC To Buy From Hold, Keeps Target At 5,900p
----------
PANMURE RAISES STANDARD LIFE TO 'BUY' ('HOLD') - TARGET 433 PENCE
----------
BERNSTEIN CUTS ARM TO 'UNDERPERFORM' ('MARKET-PERFORM') - PRICE TARGET 760 (800) PENCE
----------
LBBW CUTS BP PRICE TARGET TO 375 (450) PENCE - 'BUY'
----------
JPMORGAN CUTS STANDARD CHARTERED PRICE TARGET TO 725 (870) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS HSBC PRICE TARGET TO 430 (500) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS BARCLAYS PRICE TARGET TO 260 (290) PENCE - 'OVERWEIGHT'
----------
Cantor Fitzgerald Ups IAG To Hold From Sell, Target At 520p
----------
HSBC CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 2525 (2700) PENCE - 'BUY'
----------
UBS CUTS SMITH & NEPHEW TO 'NEUTRAL' ('BUY') - TARGET 1100 (1250) PENCE
----------
UBS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1420 (1400) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES SSE PRICE TARGET TO 1550 (1530) PENCE - 'HOLD'
----------
BERENBERG CUTS CENTRICA PRICE TARGET TO 230 (310) PENCE - 'BUY'
----------
RBC CAPITAL MARKETS UPGRADES SHIRE TO 'OUTPERFORM' FROM 'SECTOR PERFORM' WITH USD240 PRICE TARGET
----------
MORGAN STANLEY CUTS ANTOFAGASTA PRICE TARGET TO 410 (420) PENCE - 'UNDERWEIGHT'
----------
FTSE 250
----------
PANMURE CUTS ENTERPRISE INNS PRICE TARGET TO 100 (125) PENCE - 'HOLD'
----------
PANMURE CUTS CLS HLDGS PRICE TARGET TO 2016 (2610) PENCE - 'BUY'
----------
JPMORGAN CUTS IMI PRICE TARGET TO 816 (930) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES QINETIQ PRICE TARGET TO 270 (265) PENCE - 'NEUTRAL'
----------
Deutsche Bank Ups Dunelm Group Target To 885p From 870p, Keeps Hold
----------
JEFFERIES RAISES TULLOW OIL PRICE TARGET TO 166 (140) PENCE - 'HOLD'
----------
JEFFERIES CUTS STAGECOACH PRICE TARGET TO 280 (373) PENCE - 'HOLD'
----------
Liberum Cuts Interserve To Hold From Buy, Cuts Target To 440p From 625p
----------
EXANE BNP RAISES WOOD GROUP PRICE TARGET TO 645 (635) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS PETROFAC PRICE TARGET TO 890 (980) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS AMEC PRICE TARGET TO 400 (520) PENCE - 'NEUTRAL'
----------
PANMURE RAISES GREENE KING PRICE TARGET TO 1090 (1079) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
Deutsche Bank Ups Aquarius Platinum Target To 13.5p from 12.9p, Keeps Buy
----------
Liberum Rates Plus500 Buy From Under Review, 567p Target Price
----------
CITIGROUP CUTS CHEMRING GROUP PRICE TARGET TO 130 PENCE - 'NEUTRAL'
----------
Liberum Cuts Fenner Price Target To 110p From 145p, Keeps Hold
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.